ISPC ISPECIMEN INC

iSpecimen to Participate in Maxim’s 2022 Virtual Growth Conference on March 28-30, 2022

iSpecimen to Participate in Maxim’s 2022 Virtual Growth Conference on March 28-30, 2022

LEXINGTON, Mass., March 15, 2022 (GLOBE NEWSWIRE) -- (Nasdaq: ISPC) (“iSpecimen” or the “Company”), a global, proprietary online marketplace connecting scientists with healthcare providers to search for biospecimens needed for medical research, today announced that Christopher Ianelli, MD, PhD, CEO and President of iSpecimen, will participate in Maxim Group’s 2022 Virtual Growth Conference to be held virtually on March 28-30, 2022.

Dr. Ianelli's corporate presentation will be available on-demand starting Monday, March 28, 2022, at 9:00 a.m. ET for all registrants of the virtual conference. To attend, please register .



For more information about the Maxim conference, or to schedule a one-on-one meeting with iSpecimen’s management, please contact your appropriate Maxim representative directly, or send an email to KCSA Strategic Communications at .

About iSpecimen

iSpecimen (Nasdaq: ISPC) offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers and other healthcare organizations. For more information, please visit .

For further information, please contact:

Investor Contact

KCSA Strategic Communications

Allison Soss

Media Contact

KCSA Strategic Communications

Caitlin Kasunich / Raquel Cona



EN
15/03/2022

Underlying

ISPCISPECIMEN INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ISPECIMEN INC

 PRESS RELEASE
Free
ISPC ISPECIMEN INC

iSpecimen Inc. Announces Pricing of ~$5.5 Million Private Placement

iSpecimen Inc. Announces Pricing of ~$5.5 Million Private Placement WOBURN, Mass., Dec. 30, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it entered into a securities purchase agreement with accredited investors for aggregate gross proceeds of approximately $5.5 million, before deducting fees to the placement agent and other offering expenses payable by the Company. In connection w...

December 30, 2025 1 EN
 PRESS RELEASE
Free
ISPC ISPECIMEN INC

iSpecimen Inc. Announces Closing of Approximately $1.75 Million Privat...

iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market WOBURN, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it closed its previously announced private placement pursuant to a securities purchase agreement with accredited investors for aggregate gross proceeds of approximately $1.75 million, before deducting fees to the...

August 4, 2025 1 EN
 PRESS RELEASE
Free
ISPC ISPECIMEN INC

iSpecimen Inc. Announces Pricing of Approximately $1.75 Million Privat...

iSpecimen Inc. Announces Pricing of Approximately $1.75 Million Private Placement Priced At-the-Market WOBURN, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it entered into a securities purchase agreement with accredited investors for aggregate gross proceeds of approximately $1.75 million, before deducting fees to the placement agent and other offering expenses paya...

July 31, 2025 1 EN
 PRESS RELEASE
Free
ISPC ISPECIMEN INC

Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritte...

Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering WOBURN, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- This press release corrects a version issued on July 25, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen’s investor relations contact. KCSA is not currently affiliated with iSpecimen Inc. and was mistakenly included in the prior release. The corrected release is below in its entirety. iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical re...

July 28, 2025 1 EN
 PRESS RELEASE
Free
ISPC ISPECIMEN INC

Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritte...

Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering WOBURN, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- This press release corrects the version issued on July 24, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen’s investor relations contact. KCSA is not currently affiliated with iSpecimen Inc. and was mistakenly included in the prior release. The corrected release is below in its entirety. . (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with...

July 28, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch